Pharmagene, GSK discovery technology deal

Pharmagene (LSE:PGN) granted GlaxoSmithKline (LSE:GSK; GSK) access to PGN's Phase Zero lead identification and optimization technology. All of GSK's seven global Centers of Excellence for Drug Discove...